Ahead of the company’s second-quarter earnings call Aug. 6, Oscar Health is slashing its full-year guidance by about half a ...

Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, announced today certain ...

Oscar Health, Inc. (OSCR) closed at $14.20 in the latest trading session, marking a -10.52% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.07% for the day.

The health insurance agency said Tuesday it now expects a medical loss ratio of 86% to 87% for the full year, with total revenue now seen at $12 billion to $12.2 billion and a loss from operations of ...

Fintel reports that on July 25, 2025, Baird downgraded their outlook for Oscar Health (NYSE:OSCR) from Outperform to Neutral.

Oscar's strong revenue growth, improving profitability, and efficient SG&A management support my positive outlook. Read why ...

Oscar Health (NYSE:OSCR) stock fell 3.5% after the healthcare technology company revised its 2025 financial guidance following a review of second quarter Marketplace data that revealed ...

Oscar Health Thursday reported an $87 million loss in its first quarter as a publicly traded company even as revenue rose on new business and expansion into new markets to sell health insurance.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...

Oscar Health’s first-quarter financial results, its first since a $1.4 billion IPO in March, have the tech-focused insurance company’s cheerleaders celebrating. But skeptics point to a glaring ...

Is OSCR in Good Health? Oscar Health (NYSE:OSCR) is a technology-driven health insurance company specializing in individual, ...

Oscar Health CEO Mario Schlosser speaks at the 2017 Best in the Business Awards at Trianon Ballroom ... More at The New York Hilton Midtown on November 9, 2017 in New York City.